TX
Texas House Bill HB1333

Texas 2013 - 83rd Regular

Texas House Bill HB1333 Compare Versions

The same version is selected twice. Please select two different versions to compare.
OldNewDifferences
11 83R13830 JSC-F
22 By: Perry, et al. H.B. No. 1333
33 Substitute the following for H.B. No. 1333:
44 By: Herrero C.S.H.B. No. 1333
55
66
77 A BILL TO BE ENTITLED
88 AN ACT
99 relating to the designation of certain synthetic compounds to
1010 Penalty Group 2 or 2-A of the Texas Controlled Substances Act.
1111 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
1212 SECTION 1. Sections 481.002(5) and (6), Health and Safety
1313 Code, are amended to read as follows:
1414 (5) "Controlled substance" means a substance,
1515 including a drug, an adulterant, and a dilutant, listed in
1616 Schedules I through V or Penalty Group [Groups] 1, 1-A, [or] 2, 2-A,
1717 3, or [through] 4. The term includes the aggregate weight of any
1818 mixture, solution, or other substance containing a controlled
1919 substance.
2020 (6) "Controlled substance analogue" means:
2121 (A) a substance with a chemical structure
2222 substantially similar to the chemical structure of a controlled
2323 substance in Schedule I or II or Penalty Group 1, 1-A, [or] 2, or
2424 2-A; or
2525 (B) a substance specifically designed to produce
2626 an effect substantially similar to, or greater than, the effect of a
2727 controlled substance in Schedule I or II or Penalty Group 1, 1-A,
2828 [or] 2, or 2-A.
2929 SECTION 2. Section 481.103(a), Health and Safety Code, is
3030 amended to read as follows:
3131 (a) Penalty Group 2 consists of:
3232 (1) any quantity of the following hallucinogenic
3333 substances, their salts, isomers, and salts of isomers, unless
3434 specifically excepted, if the existence of these salts, isomers,
3535 and salts of isomers is possible within the specific chemical
3636 designation:
3737 alpha-ethyltryptamine;
3838 alpha-methyltryptamine;
3939 5-(2-aminopropyl)benzofuran (5-APB);
4040 6-(2-aminopropyl)benzofuran (6-APB);
4141 5-(2-aminopropyl)-2,3-dihydrobenzofuran
4242 (5-APDB);
4343 6-(2-aminopropyl)-2,3-dihydrobenzofuran
4444 (6-APDB);
4545 5-(2-aminopropyl)indole (Trade or other names:
4646 5-IT, 5-API);
4747 6-(2-aminopropyl)indole (Trade or other names:
4848 6-IT, 6-API);
4949 Benzothiophenylcyclohexylpiperidine (BTCP);
5050 4-bromo-2, 5-dimethoxyamphetamine (some trade or
5151 other names: 4-bromo-2, 5-dimethoxy-alpha-methylphenethylamine;
5252 4-bromo-2, 5-DMA);
5353 4-bromo-2, 5-dimethoxyphenethylamine;
5454 8-bromo-alpha-methyl-benzo[1,2-b:4,5-b']difuran-
5555 4-ethanamine (Trade or other name: Bromo-DragonFLY);
5656 Bufotenine (some trade and other names: 3-(beta-
5757 Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)- 5-
5858 indolol; N, N-dimethylserotonin; 5-hydroxy-N, N-
5959 dimethyltryptamine; mappine);
6060 Desoxypipradrol (2-benzhydrylpiperidine);
6161 Diethyltryptamine (some trade and other names: N,
6262 N-Diethyltryptamine, DET);
6363 2, 5-dimethoxyamphetamine (some trade or other
6464 names: 2, 5-dimethoxy-alpha-methylphenethylamine; 2, 5-DMA);
6565 2, 5-dimethoxy-4-ethylamphetamine (trade or other
6666 name: DOET);
6767 2, 5-dimethoxy-4-(n)-propylthiophenethylamine
6868 (trade or other name: 2C-T-7);
6969 Dimethyltryptamine (trade or other name: DMT);
7070 Diphenylprolinol (diphenyl(pyrrolidin-2-yl)
7171 methanol, D2PM);
7272 Dronabinol (synthetic) in sesame oil and
7373 encapsulated in a soft gelatin capsule in a U.S. Food and Drug
7474 Administration approved drug product (some trade or other names for
7575 Dronabinol: (a6aR-trans)-6a,7,8,10a-tetrahydro- 6,6, 9-
7676 trimethyl-3-pentyl-6H- dibenzo [b,d]pyran-1-ol or (-)-delta-9-
7777 (trans)- tetrahydrocannabinol);
7878 Ethylamine Analog of Phencyclidine (some trade or
7979 other names: N-ethyl-1-phenylcyclohexylamine, (1-
8080 phenylcyclohexyl) ethylamine, N-(1-phenylcyclohexyl) ethylamine,
8181 cyclohexamine, PCE);
8282 2-ethylamino-2-(3-methoxyphenyl)cyclohexanone
8383 (Trade or other name: methoxetamine);
8484 Ibogaine (some trade or other names: 7-Ethyl-6,
8585 6, beta 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5H-
8686 pyrido [1', 2':1, 2] azepino [5, 4-b] indole; tabernanthe iboga.);
8787 5-iodo-2-aminoindiane (5-IAI);
8888 Mescaline;
8989 5-methoxy-N, N-diisopropyltryptamine
9090 (5-MeO-DIPT);
9191 5-methoxy-N, N-diallyltryptamine (5MeO-DALT);
9292 5-methoxy-3, 4-methylenedioxy amphetamine;
9393 4-methoxyamphetamine (some trade or other names:
9494 4-methoxy-alpha-methylphenethylamine; paramethoxyamphetamine;
9595 PMA);
9696 4-methoxymethamphetamine (PMMA);
9797 2-(2-methoxyphenyl)-2-(methylamino)cyclohexanone
9898 (Trade or other names: 2-MeO-ketamine; methoxyketamine);
9999 1-methyl- 4-phenyl-4-propionoxypiperidine (MPPP,
100100 PPMP);
101101 4-methyl-2, 5-dimethoxyamphetamine (some trade
102102 and other names: 4-methyl-2, 5-dimethoxy-alpha-
103103 methylphenethylamine; "DOM"; "STP");
104104 3,4-methylenedioxy methamphetamine (MDMA, MDM);
105105 3,4-methylenedioxy amphetamine;
106106 3,4-methylenedioxy N-ethylamphetamine (Also
107107 known as N-ethyl MDA);
108108 5,6-methylenedioxy-2-aminoindane (MDAI);
109109 Nabilone (Another name for nabilone: (+)-trans-
110110 3-(1,1-dimethylheptyl)- 6,6a, 7,8,10,10a-hexahydro-1-hydroxy- 6,
111111 6-dimethyl-9H-dibenzo[b,d] pyran-9-one;
112112 N-benzylpiperazine (some trade or other names:
113113 BZP; 1-benzylpiperazine);
114114 N-ethyl-3-piperidyl benzilate;
115115 N-hydroxy-3,4-methylenedioxyamphetamine (Also
116116 known as N-hydroxy MDA);
117117 4-methylaminorex;
118118 N-methyl-3-piperidyl benzilate;
119119 O-Acetylpsilocin (Trade or other name:
120120 4-Aco-DMT);
121121 Parahexyl (some trade or other names: 3-Hexyl-1-
122122 hydroxy-7, 8, 9, 10-tetrahydro-6, 6, 9-trimethyl-6H-dibenzo [b, d]
123123 pyran; Synhexyl);
124124 1-Phenylcyclohexylamine;
125125 1-Piperidinocyclohexanecarbonitrile (PCC);
126126 Psilocin;
127127 Psilocybin;
128128 Pyrrolidine Analog of Phencyclidine (some trade
129129 or other names: 1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP);
130130 Tetrahydrocannabinols, other than marihuana, and
131131 synthetic equivalents of the substances contained in the plant, or
132132 in the resinous extractives of Cannabis, or synthetic substances,
133133 derivatives, and their isomers with similar chemical structure and
134134 pharmacological activity such as:
135135 delta-1 cis or trans tetrahydrocannabinol,
136136 and their optical isomers;
137137 delta-6 cis or trans tetrahydrocannabinol,
138138 and their optical isomers;
139139 delta-3, 4 cis or trans
140140 tetrahydrocannabinol, and its optical isomers;
141141 compounds of these structures, regardless of
142142 numerical designation of atomic positions, since nomenclature of
143143 these substances is not internationally standardized;
144144 Thiophene Analog of Phencyclidine (some trade or
145145 other names: 1-[1-(2-thienyl) cyclohexyl] piperidine; 2-Thienyl
146146 Analog of Phencyclidine; TPCP, TCP);
147147 1-pyrrolidine (some trade or other name: TCPy);
148148 1-(3-trifluoromethylphenyl)piperazine (trade or
149149 other name: TFMPP); and
150150 3,4,5-trimethoxy amphetamine;
151151 (2) Phenylacetone (some trade or other names:
152152 Phenyl-2-propanone; P2P, Benzymethyl ketone, methyl benzyl
153153 ketone);
154154 (3) unless specifically excepted or unless listed in
155155 another Penalty Group, a material, compound, mixture, or
156156 preparation that contains any quantity of the following substances
157157 having a potential for abuse associated with a depressant or
158158 stimulant effect on the central nervous system:
159159 Aminorex (some trade or other names: aminoxaphen;
160160 2-amino-5-phenyl-2-oxazoline; 4,5-dihydro-5-
161161 phenyl-2-oxazolamine);
162162 Amphetamine, its salts, optical isomers, and
163163 salts of optical isomers;
164164 Cathinone (some trade or other names: 2-amino-1-
165165 phenyl-1-propanone, alpha-aminopropiophenone, 2-
166166 aminopropiophenone);
167167 Etaqualone and its salts;
168168 Etorphine Hydrochloride;
169169 Fenethylline and its salts;
170170 Lisdexamfetamine, including its salts, isomers,
171171 and salts of isomers;
172172 Mecloqualone and its salts;
173173 Methaqualone and its salts;
174174 Methcathinone (some trade or other names: 2-
175175 methylamino-propiophenone; alpha-(methylamino)propriophenone;
176176 2-(methylamino)-1-phenylpropan-1-one; alpha-N-
177177 methylaminopropriophenone; monomethylpropion; ephedrone, N-
178178 methylcathinone; methylcathinone; AL-464; AL-422; AL-463; and UR
179179 1431);
180180 N-Ethylamphetamine, its salts, optical isomers,
181181 and salts of optical isomers; and
182182 N,N-dimethylamphetamine (some trade or other
183183 names: N,N,alpha-trimethylbenzeneethaneamine;
184184 N,N,alpha-trimethylphenethylamine), its salts, optical isomers,
185185 and salts of optical isomers; and
186186 (4) any compound structurally derived from
187187 2-aminopropanal by substitution at the 1-position with any
188188 monocyclic or fused-polycyclic ring system, including:
189189 (A) compounds further modified by:
190190 (i) substitution in the ring system to any
191191 extent (including alkyl, alkoxy, alkylenedioxy, haloalkyl,
192192 hydroxyl, or halide substituents), whether or not further
193193 substituted in the ring system by other substituents;
194194 (ii) substitution at the 3-position with an
195195 acyclic alkyl substituent; or
196196 (iii) substitution at the 2-amino nitrogen
197197 atom with alkyl, [or] dialkyl, benzyl, or methoxybenzyl groups, or
198198 inclusion of the 2-amino nitrogen atom in a cyclic structure; and
199199 (B) by example, compounds such as:
200200 4-Methoxymethcathinone (Also known as
201201 Methedrone);
202202 4-Methylmethcathinone (Also known as
203203 Mephedrone);
204204 3,4-Dimethylmethcathinone (Also known as
205205 3,4-DMMC);
206206 3-Fluoromethcathinone (Also known as 3-FMC);
207207 4-Fluoromethcathinone (Also known as
208208 Flephedrone);
209209 3,4-Methylenedioxy-N-methylcathinone (Also
210210 known as Methylone);
211211 3,4-Methylenedioxypyrovalerone (Also known
212212 as MDPV);
213213 alpha-Pyrrolidinopentiophenone (Also known
214214 as alpha-PVP);
215215 Naphthylpyrovalerone (Also known as
216216 Naphyrone);
217217 beta-Keto-N-methylbenzodioxolylpropylamine
218218 (Also known as Butylone);
219219 beta-Keto-N-methylbenzodioxolylpentanamine
220220 (Also known as Pentylone);
221221 beta-Keto-Ethylbenzodioxolylbutanamine
222222 (Also known as Eutylone); and
223223 3,4-methylenedioxy-N-ethylcathinone (Also
224224 known as Ethylone).
225225 SECTION 3. Section 481.1031, Health and Safety Code, is
226226 amended to read as follows:
227227 Sec. 481.1031. PENALTY GROUP 2-A. Penalty Group 2-A
228228 consists of any quantity of a synthetic chemical compound that is a
229229 cannabinoid receptor agonist and mimics the pharmacological effect
230230 of naturally occurring cannabinoids, including:
231231 naphthoylindoles structurally derived from
232232 3-(1-naphthoyl)indole with or without [by] substitution at the
233233 nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl,
234234 cycloalkylmethyl, cycloalkylethyl, (N-methylpiperidin-2-yl)
235235 methyl, cyanoalkyl, (N-methylpyrrolidin-2-yl)methyl,
236236 (tetrahydropyran-4-yl)methyl, ((N-methyl)-3-morpholinyl)methyl,
237237 or 2-(4-morpholinyl)ethyl, whether or not further substituted in
238238 the indole ring to any extent, whether or not substituted in the
239239 napthyl ring to any extent, including:
240240 AM-2201;
241241 JWH-004;
242242 JWH-007;
243243 JWH-009;
244244 JWH-015;
245245 JWH-016;
246246 JWH-018;
247247 JWH-019;
248248 JWH-020;
249249 JWH-046;
250250 JWH-047;
251251 JWH-048;
252252 JWH-049;
253253 JWH-050;
254254 JWH-073;
255255 JWH-076;
256256 JWH-079;
257257 JWH-080;
258258 JWH-081;
259259 JWH-082;
260260 JWH-083;
261261 JWH-093;
262262 JWH-094;
263263 JWH-095;
264264 JWH-096;
265265 JWH-097;
266266 JWH-098;
267267 JWH-099;
268268 JWH-100;
269269 JWH-116;
270270 JWH-122;
271271 JWH-148;
272272 JWH-149;
273273 JWH-153;
274274 JWH-159;
275275 JWH-164;
276276 JWH-165;
277277 JWH-166;
278278 JWH-180;
279279 JWH-181;
280280 JWH-182;
281281 JWH-189;
282282 JWH-193;
283283 JWH-198;
284284 JWH-200;
285285 JWH-210;
286286 JWH-211;
287287 JWH-212;
288288 JWH-213;
289289 JWH-234;
290290 JWH-235;
291291 JWH-239;
292292 JWH-240;
293293 JWH-241;
294294 JWH-242;
295295 JWH-258;
296296 JWH-259;
297297 JWH-260;
298298 JWH-262;
299299 JWH-267;
300300 JWH-386;
301301 JWH-387;
302302 JWH-394;
303303 JWH-395;
304304 JWH-397;
305305 JWH-398;
306306 JWH-399;
307307 JWH-400;
308308 JWH-412;
309309 JWH-413; and
310310 JWH-414;
311311 naphthylmethylindones structurally derived from
312312 1H-indol-3-yl-(1-naphthyl)methane with or without [by]
313313 substitution at the nitrogen atom of the indole ring by alkyl,
314314 haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
315315 (N-methylpiperidin-2-yl)methyl, cyanoalkyl, (N-methylpyrrolidin-
316316 2-yl)methyl, (tetrahydropyran-4-yl)methyl, ((N-methyl)-3-
317317 morpholinyl)methyl, or 2-(4-morpholinyl)ethyl, whether or not
318318 further substituted in the indole ring to any extent, whether or not
319319 substituted in the naphthyl ring to any extent, including:
320320 JWH-175;
321321 JWH-184;
322322 JWH-185;
323323 JWH-192;
324324 JWH-194;
325325 JWH-195;
326326 JWH-196;
327327 JWH-197; and
328328 JWH-199;
329329 naphthoylpyrroles structurally derived from
330330 3-(1-naphthoyl)pyrrole with or without [by] substitution at the
331331 nitrogen atom of the pyrrole ring by alkyl, haloalkyl, alkenyl,
332332 cycloalkylmethyl, cycloalkylethyl, (N-methylpiperidin-2-yl)
333333 methyl, cyanoalkyl, (N-methylpyrrolidin-2-yl)methyl,
334334 (tetrahydropyran-4-yl)methyl, ((N-methyl)-3-morpholinyl)methyl,
335335 or 2-(4-morpholinyl)ethyl, whether or not further substituted in
336336 the pyrrole ring to any extent, whether or not substituted in the
337337 naphthyl ring to any extent, including:
338338 JWH-030;
339339 JWH-145;
340340 JWH-146;
341341 JWH-147;
342342 JWH-150;
343343 JWH-156;
344344 JWH-243;
345345 JWH-244;
346346 JWH-245;
347347 JWH-246;
348348 JWH-292;
349349 JWH-293;
350350 JWH-307;
351351 JWH-308;
352352 JWH-309;
353353 JWH-346;
354354 JWH-347;
355355 JWH-348;
356356 JWH-363;
357357 JWH-364;
358358 JWH-365;
359359 JWH-366;
360360 JWH-367;
361361 JWH-368;
362362 JWH-369;
363363 JWH-370;
364364 JWH-371;
365365 JWH-372;
366366 JWH-373; and
367367 JWH-392;
368368 naphthylmethylindenes structurally derived from
369369 1-(1-naphthylmethyl)indene with or without [by] substitution at
370370 the 3-position of the indene ring by alkyl, haloalkyl, alkenyl,
371371 cycloalkylmethyl, cycloalkylethyl, (N-methylpiperidin-2-yl)
372372 methyl, cyanoalkyl, (N-methylpyrrolidin-2-yl)methyl,
373373 (tetrahydropyran-4-yl)methyl, ((N-methyl)-3-morpholinyl)methyl,
374374 or 2-(4-morpholinyl)ethyl, whether or not further substituted in
375375 the indene ring to any extent, whether or not substituted in the
376376 naphthyl ring to any extent, including:
377377 JWH-171;
378378 JWH-172;
379379 JWH-173; and
380380 JWH-176;
381381 phenylacetylindoles structurally derived from
382382 3-phenylacetylindole with or without [by] substitution at the
383383 nitrogen atom of the indole ring with alkyl, haloalkyl, alkenyl,
384384 cycloalkylmethyl, cycloalkylethyl, (N-methylpiperidin-2-yl)
385385 methyl, cyanoalkyl, (N-methylpyrrolidin-2-yl)methyl,
386386 (tetrahydropyran-4-yl)methyl, ((N-methyl)-3-morpholinyl)methyl,
387387 or 2-(4-morpholinyl)ethyl, whether or not further substituted in
388388 the indole ring to any extent, whether or not substituted in the
389389 phenyl ring to any extent, including:
390390 AM-694;
391391 AM-1241;
392392 JWH-167;
393393 JWH-203;
394394 JWH-204;
395395 JWH-205;
396396 JWH-206;
397397 JWH-208;
398398 JWH-237;
399399 JWH-248;
400400 JWH-249;
401401 JWH-250;
402402 JWH-251;
403403 JWH-252;
404404 JWH-253;
405405 JWH-302;
406406 JWH-303;
407407 JWH-305;
408408 JWH-306;
409409 JWH-311;
410410 JWH-312;
411411 JWH-313;
412412 JWH-314; and
413413 JWH-315;
414414 cyclohexylphenols structurally derived from
415415 2-(3-hydroxycyclohexyl)phenol with or without [by] substitution at
416416 the 5-position of the phenolic ring by alkyl, haloalkyl, alkenyl,
417417 cycloalkylmethyl, cycloalkylethyl, (N-methylpiperidin-2-yl)
418418 methyl, cyanoalkyl, (N-methylpyrrolidin-2-yl)methyl,
419419 (tetrahydropyran-4-yl)methyl, ((N-methyl)-3-morpholinyl)methyl,
420420 or 2-(4-morpholinyl)ethyl, whether or not substituted in the
421421 cyclohexyl ring to any extent, including:
422422 CP-55,940;
423423 CP-47,497;
424424 analogues of CP-47,497, including VII, V, VIII, I,
425425 II, III, IV, IX, X, XI, XII, XIII, XV, and XVI;
426426 JWH-337;
427427 JWH-344;
428428 JWH-345; and
429429 JWH-405; [and]
430430 benzoylindoles structurally derived from
431431 3-(1-naphthoyl)indole with or without substitution at the nitrogen
432432 atom of the indole ring with alkyl, haloalkyl, alkenyl,
433433 cycloalkylmethyl, cycloalkylethyl, (N-methylpiperidin-2-yl)
434434 methyl, cyanoalkyl, (N-methylpyrrolidin-2-yl)methyl,
435435 (tetrahydropyran-4-yl)methyl, ((N-methyl)-3-morpholinyl)methyl,
436436 or 2-(4-morpholinyl)ethyl, whether or not further substituted in
437437 the indole ring to any extent, whether or not substituted in the
438438 phenyl ring to any extent, including:
439439 1-pentyl-3-(4-methoxybenzoyl)indole (RCS-4); and
440440 1-[2-(4-morpholinyl)ethyl]-2-methyl-3-(4-
441441 methoxybenzoyl)indole (Pravadoline or WIN 48,098); and
442442 cannabinol derivatives, except where contained in
443443 marihuana, including tetrahydro derivatives of cannabinol and
444444 3-alkyl homologues of cannabinol or of its tetrahydro derivatives,
445445 such as:
446446 Nabilone;
447447 HU-210;
448448 HU-211; and
449449 WIN-55,212-2.
450450 SECTION 4. Section 481.106, Health and Safety Code, is
451451 amended to read as follows:
452452 Sec. 481.106. CLASSIFICATION OF CONTROLLED SUBSTANCE
453453 ANALOGUE. For the purposes of the prosecution of an offense under
454454 this subchapter involving the manufacture, delivery, or possession
455455 of a controlled substance, Penalty Groups 1, 1-A, [and] 2, and 2-A
456456 include a controlled substance analogue that:
457457 (1) has a chemical structure substantially similar to
458458 the chemical structure of a controlled substance listed in the
459459 applicable penalty group; or
460460 (2) is specifically designed to produce an effect
461461 substantially similar to, or greater than, a controlled substance
462462 listed in the applicable penalty group.
463463 SECTION 5. The change in law made by this Act applies only
464464 to an offense committed on or after the effective date of this Act.
465465 An offense committed before the effective date of this Act is
466466 governed by the law in effect on the date the offense was committed,
467467 and the former law is continued in effect for that purpose. For
468468 purposes of this section, an offense was committed before the
469469 effective date of this Act if any element of the offense occurred
470470 before that date.
471471 SECTION 6. This Act takes effect September 1, 2013.